Biotechnology Research Corporation of Hong Kong

Biotechnology Research Corporation (BRC) is a commercialization and research entity established by the Hong Kong University of Science and Technology (HKUST) to bridge the gap between academic discovery and industrial application. The company focuses on translating high-impact research in neuroscience, molecular diagnostics, and the modernization of Traditional Chinese Medicine (TCM) into viable healthcare products. BRC manages a portfolio of intellectual property and facilitates strategic collaborations with global pharmaceutical companies to develop innovative treatments for age-related diseases. Its primary mission involves the development of early diagnostic tools and therapeutic interventions for neurodegenerative conditions like Alzheimer's disease. By leveraging HKUST's scientific infrastructure, BRC serves as a key player in Hong Kong's biotechnology ecosystem.